Ramiro Zurita, MD | |
515 Wekiva Commons Cir, Apopka, FL 32712-3645 | |
(407) 464-9516 | |
(407) 464-9519 |
Full Name | Ramiro Zurita |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 515 Wekiva Commons Cir, Apopka, Florida |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1134167232 | NPI | - | NPPES |
25419 | Other | FL | BCBS INDIVIDUAL NUMBER |
375954700 | Medicaid | FL | |
269683500 | Medicaid | FL |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208M00000X | Hospitalist | ME66550 (Florida) | Primary |
207R00000X | Internal Medicine | ME66550 (Florida) | Secondary |
Mailing Address | Practice Location Address |
---|---|
Ramiro Zurita, MD 515 Wekiva Commons Cir, Apopka, FL 32712-3645 Ph: (407) 464-9516 | Ramiro Zurita, MD 515 Wekiva Commons Cir, Apopka, FL 32712-3645 Ph: (407) 464-9516 |
News Archive
Biologic age, a DNA-based estimate of a person's age, is associated with future development of breast cancer, according to scientists at the National Institutes of Health.
Myrexis, Inc., a biotechnology company focused on discovering, developing, and commercializing novel treatments for cancer, today announced it will present a poster at the Cancer and Metabolism: Pathways to the Future meeting in Edinburgh, Scotland, as well as two additional posters at the 22nd European Organisation for Research and Treatment of Cancer (EORTC), National Cancer Institute (NCI) and American Association for Cancer Research (AACR) Symposium on "Molecular Targets and Cancer Therapeutics" November 16-19, 2010, in Berlin, Germany.
PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced the continued expansion of its clinical trial site alliance network, an extensive network of investigator sites and Site Management Organizations (SMOs) that enables PAREXEL to quickly access and enroll patient populations for clients' clinical trials worldwide.
MSH's "Global Health Impact" blog provides a Storify summary of a Washington Post Live panel discussion on non-communicable diseases (NCDs) that took place last week.
Nucleix, Ltd., an emerging life science company specializing in forensic DNA analysis, announced that company researchers today presented its DNA authentication technology, a novel assay to distinguish between in-vivo (real) and in-vitro (fake) DNA, at the 20th International Symposium on Human Identification in Las Vegas, Nevada.
› Verified 6 days ago
Yorlenis Rodriguez, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 201 N Park Ave, Apopka, FL 32703 Phone: 407-889-1953 | |
Dr. Louis Padgett, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 515 Wekiva Commons Cir, Apopka, FL 32712 Phone: 407-464-9519 Fax: 407-464-9519 | |
Dr. Bolanle Akakabota, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 515 Wekiva Commons Cir, Apopka, FL 32712 Phone: 407-464-9516 | |
Zaid Tabbaa, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 515 Wekiva Commons Cir, Apopka, FL 32712 Phone: 407-464-9516 Fax: 407-464-9519 | |
Leah Delumpa, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 515 Wekiva Commons Cir, Apopka, FL 32712 Phone: 407-464-9516 Fax: 407-464-9519 | |
Dr. Soheil Peiman, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 515 Wekiva Commons Cir, Apopka, FL 32712 Phone: 407-464-9516 Fax: 407-464-9519 |